Patent ID: 11903928
Assignee: CLEXIO BIOSCIENCES LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 12:
13. The method of claim 12, wherein the additional active agent is selected from the group consisting of corticosteroids, doxepine, tacrolimus, pimecrolimus, pramoxine, lidocaine, prilocaine, ketamine, amitriptyline, capsaicin, menthol, camphor, strontium, tofacitinib, crisaborole, N-palmitoylethanolamine, an antihistamine, an SNRI, an SSRI, naltrexone, butophanol, nalfurafine, gabapentin, pregabalin, aprepitant, thalidomide, lenalidomide, ursodeoxycholic acid, rifampin, cholestyramine, phenobarbital, Botulinum toxin A, naloxone, ASNO08, SNA-125, TS-022, KPL-716 or orvepitant.